4.8 Review

Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies

Journal

GASTROENTEROLOGY
Volume 160, Issue 6, Pages 1947-1960

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2020.12.080

Keywords

Colorectal Cancer; Cancer Stem Cells; Omic Technologies; Single-Cell Analyses; Intra-Tumor Heterogeneity; Targeted Therapies

Funding

  1. Veterans Affairs Biomedical Laboratory Research and Development [1I01BX000516, I01BX003771]
  2. Veterans Affairs Rehabilitation Research and Development [1I01RX000989]
  3. Department of Defense Translational Team Science Award
  4. National Institutes of Health/National Cancer Institute [R01CA113796, R01CA158467, R01CA138231]

Ask authors/readers for more resources

The concept of cancer stem cells (CSCs) suggests a hierarchy within tumors where a minority of more primitive cells give rise to more differentiated cells that make up the tumor bulk, but are not capable of perpetuating tumors on their own. CSCs may drive therapeutic resistance and cancer progression, and their identification and isolation methods have been established. Single-cell omics technologies offer opportunities to discover novel molecular pathways for CRC eradication.
The cancer stem cell (CSC) concept emerged from the recognition of inherent tumor heterogeneity and suggests that within a given tumor, in analogy to normal tissues, there exists a cellular hierarchy composed of a minority of more primitive cells with enhanced longevity (ie, CSCs) that give rise to shorter-lived, more differentiated cells (ie, cancer bulk populations), which on their own are not capable of tumor perpetuation. CSCs can be responsible for cancer therapeutic resistance to conventional, targeted, and immunotherapeutic treatment modalities, and for cancer progression through CSC-intrinsic molecular mechanisms. The existence of CSCs in colorectal cancer (CRC) was first established through demonstration of enhanced clonogenicity and tumor-forming capacity of this cell subset in human-to-mouse tumor xenotransplantation experiments and subsequently confirmed through lineage-tracing studies in mice. Surface markers for CRC CSC identification and their prospective isolation are now established. Therefore, the application of single-cell omics technologies to CSC characterization, including whole-genome sequencing, RNA sequencing, and epigenetic analyses, opens unprecedented opportunities to discover novel targetable molecular pathways and hence to develop novel strategies for CRC eradication. We review recent advances in this field and discuss the potential implications of next-generation CSC analyses for currently approved and experimental targeted CRC therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available